The Antidiabetic Drug Ciglitazone Induces High Grade Bladder Cancer Cells Apoptosis through the Up-Regulation of TRAIL

Cytotoxicity and apoptosis by survivin small interfering RNA in bladder cancer cells

(2010) Ja H. Ku et al.   BJU INTERNATIONAL

Caspase-mediated Cleavage of β-Catenin Precedes Drug-induced Apoptosis in Resistant Cancer Cells

(2009) Subramanian Senthivinayagam et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Rosiglitazone acts as a neuroprotectant in retinal cells via up-regulation of sestrin-1 and SOD-2

(2009) Francesca Doonan et al.   JOURNAL OF NEUROCHEMISTRY

Effects of Pioglitazone, a Peroxisome Proliferator–Activated Receptor Gamma Agonist, on the Urine and Urothelium of the Rat

(2009) Shugo Suzuki et al.   TOXICOLOGICAL SCIENCES

PPARγ-independent antitumor effects of thiazolidinediones

(2008) Shuo Wei et al.   CANCER LETTERS

Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics

(2008) A. C. Mita et al.   CLINICAL CANCER RESEARCH

A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells

(2008) Guillaume Boiteux et al.   INTERNATIONAL JOURNAL OF CANCER

FLIP and the death effector domain family

(2008) J W Yu et al.   ONCOGENE

Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP

(2007) Yeoun Hee Kim et al.   FREE RADICAL BIOLOGY AND MEDICINE

The BCL-2 protein family: opposing activities that mediate cell death

(2007) Richard J. Youle et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY